| __timestamp | Alkermes plc | BioCryst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 170914000 | 13486000 |
| Thursday, January 1, 2015 | 144942000 | 46361000 |
| Friday, January 1, 2016 | 226424000 | 23654000 |
| Sunday, January 1, 2017 | 335737000 | 23484000 |
| Monday, January 1, 2018 | 492448000 | 20182000 |
| Tuesday, January 1, 2019 | 477729000 | 44734000 |
| Wednesday, January 1, 2020 | 465852000 | 16136000 |
| Friday, January 1, 2021 | 569838000 | 149906000 |
| Saturday, January 1, 2022 | 893687000 | 264233000 |
| Sunday, January 1, 2023 | 1410368000 | 326751000 |
| Monday, January 1, 2024 | 1312301000 |
Unlocking the unknown
In the competitive world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Alkermes plc has consistently outperformed BioCryst Pharmaceuticals, Inc. in terms of gross profit. From 2014 to 2023, Alkermes saw a remarkable growth, with its gross profit increasing by over 700%, peaking at approximately $1.41 billion in 2023. In contrast, BioCryst's gross profit, while also growing, reached a more modest $327 million in the same year.
This stark difference highlights Alkermes' strategic advantage and market positioning. The data suggests that Alkermes has been more successful in scaling its operations and capturing market share. As the biotech industry continues to evolve, these financial insights provide a glimpse into the dynamics shaping the future of these two companies.
Gross Profit Comparison: Novo Nordisk A/S and BioCryst Pharmaceuticals, Inc. Trends
Gross Profit Analysis: Comparing Pfizer Inc. and BioCryst Pharmaceuticals, Inc.
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Teva Pharmaceutical Industries Limited or BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: United Therapeutics Corporation vs Alkermes plc
Who Generates Higher Gross Profit? Incyte Corporation or BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Viatris Inc. vs BioCryst Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing Exelixis, Inc. and BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Grifols, S.A. vs Alkermes plc
Corcept Therapeutics Incorporated and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Vericel Corporation and BioCryst Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis